• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Sunesis Pharmaceuticals, Inc. (SNSS)

    -NasdaqCM
    0.69 Up 0.00(0.57%) Feb 12, 4:00PM EST
    Prev Close:0.68
    Open:0.71
    Bid:0.70 x 500
    Ask:0.81 x 8200
    1y Target Est:2.08
    Beta:1.34271
    Earnings Date:Mar 10 - Mar 14 (Est.)
    Day's Range:0.66 - 0.72
    52wk Range:0.65 - 3.72
    Volume:126,330
    Avg Vol (3m):298,958
    Market Cap:59.39M
    P/E (ttm):N/A
    EPS (ttm):-0.44
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SNSS

    Comparison

    Symbol% ChgMkt Cap
    SNSSUp 0.57%59.39M
    AZNUp 1.75%74.98B
    PFEUp 0.79%181.25B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):15.68
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.49
    Quarterly EPS Est (Dec-15) :-0.14
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.01

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback